ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 173 filers reported holding ACCELERON PHARMA INC in Q3 2018. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $21,000 | -16.0% | 528 | -13.2% | 0.00% | 0.0% |
| Q2 2019 | $25,000 | -89.5% | 608 | -88.2% | 0.00% | -87.5% |
| Q1 2019 | $239,000 | +6.2% | 5,136 | -0.6% | 0.01% | -11.1% |
| Q4 2018 | $225,000 | -56.3% | 5,168 | -42.5% | 0.01% | -47.1% |
| Q3 2018 | $515,000 | +15.7% | 8,992 | -1.9% | 0.02% | +13.3% |
| Q2 2018 | $445,000 | +39.5% | 9,168 | +12.4% | 0.02% | +36.4% |
| Q1 2018 | $319,000 | – | 8,160 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 1,400,000 | $133,378,000 | 3.73% |
| Foresite Capital Management III, LLC | 42,030 | $4,004,000 | 3.56% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 257,249 | $24,508,000 | 2.23% |
| Cormorant Asset Management, LP | 600,000 | $57,162,000 | 2.18% |
| Avoro Capital Advisors LLC | 1,040,000 | $99,081,000 | 1.96% |
| QVT Financial LP | 101,396 | $9,660,000 | 1.64% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,100,000 | $200,067,000 | 1.60% |
| Rhenman & Partners Asset Management AB | 155,000 | $14,767,000 | 1.60% |
| Parkman Healthcare Partners LLC | 57,500 | $5,478,000 | 1.54% |
| Ikarian Capital, LLC | 187,700 | $17,882,000 | 1.42% |